Urothelial carcinoma with osteoclast-like giant cells: An expanded immunohistochemical and molecular profile. Read more about Urothelial carcinoma with osteoclast-like giant cells: An expanded immunohistochemical and molecular profile.
Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry. Read more about Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.
Transcriptomic Analysis of Cirrhosis-Like Hepatocellular Carcinoma Reveals Distinct Molecular Characteristics and Pathologic Staging Implications. Read more about Transcriptomic Analysis of Cirrhosis-Like Hepatocellular Carcinoma Reveals Distinct Molecular Characteristics and Pathologic Staging Implications.
Global Cytopathology-Hematopathology Practice Trends. Read more about Global Cytopathology-Hematopathology Practice Trends.
Corrigendum to: Global Cytopathology-Hematopathology Practice Trends. Read more about Corrigendum to: Global Cytopathology-Hematopathology Practice Trends.
Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations. Read more about Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations.
Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma. Read more about Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
Abdominopelvic and Retroperitoneal Low-Grade Fibromyxoid Sarcoma: A Clinicopathologic Study of 13 Cases. Read more about Abdominopelvic and Retroperitoneal Low-Grade Fibromyxoid Sarcoma: A Clinicopathologic Study of 13 Cases.
Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks. Read more about Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks.
Simulators of cutaneous lymphoma: where should our efforts go? Read more about Simulators of cutaneous lymphoma: where should our efforts go?
